TrialPloS one2021

A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer.

Stephanie I Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.